As Vice President of Technology Ventures, Manu Nair is focused on building partnerships with industry that advance the research in OMRF’s laboratories and translate our discoveries into diagnostics and therapeutics for human disease. Nair holds a Masters in Business Administration from Lamar University and a Masters of Law from the Franklin Pierce Law Center of the University of New Hampshire. Nair first worked at OMRF from 2004 to 2009 as a Licensing Associate, commercializing OMRF technologies by partnering with biotechnology and pharmaceutical companies. His efforts led to the creation of Vectra DA, an advanced blood test for rheumatoid arthritis, and TZ101, an experimental drug currently undergoing clinical trials for patients with leukemia, lymphoma and other cancers. For five years, Nair served as a technology licensing manager and then senior licensing manager for Mayo Clinic Ventures at the Mayo Clinic in Rochester, MN. There, he orchestrated technology commercialization, including company formation and seed-capital investment, international collaboration, funding initiatives and strategic business development. Nair returned to OMRF in 2014 to lead the Office of Technology Ventures.
Phone: (405) 271-1823
Oklahoma Medical Research Foundation
825 N.E. 13th Street
Oklahoma City, OK 73104